Morrison & Foerster advised Crinetics Pharmaceuticals, Inc. on the offering, Wilson Sonsini Goodrich & Rosati advised Crinetics on patent matters and Cooley advised the underwriters. Crinetics...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Crinetics, and Cooley advised the underwriters on the offering. Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) announced the pricing of an upsized underwritten public...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Crinetics on the deal. Crinetics Pharmaceuticals, a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel...
You must be a Standard 1 Year member to access this content.
